Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F R Appelbaum

Showing results (261-270 of 490) with videos related to

Pageof 49
Sort By:
Leukemia Research|March 30, 2000
A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemiaP J Rosen, C Rankin, D R Head, et al.
Genes, Chromosomes & Cancer|June 22, 2000
Twenty-four-color spectral karyotyping reveals chromosome aberrations in cytogenetically normal acute myeloid leukemiaF F Zhang, J L Murata-Collins, P Gaytan, et al.
Bone Marrow Transplantation|April 1, 1996
Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levelsT Demirer, C D Buckner, F R Appelbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1987
Marrow transplantation for acute nonlymphocytic leukemia following therapy for Hodgkin's diseaseM Sargur, C D Buckner, F R Appelbaum, et al.
Blood|August 15, 1991
Graft-versus-host disease prophylaxis with methotrexate/cyclosporine in children with severe aplastic anemia treated with cyclophosphamide and HLA-identical marrow graftsR Storb, J E Sanders, M Pepe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapyJ Mortimer, M A Blinder, S Schulman, et al.
Transplantation|November 1, 1992
Succinyl acetone plus methotrexate as graft-versus-host disease prophylaxis in DLA-haploidentical canine littermate marrow graftsR F Raff, R Storb, T Graham, et al.
Annals of Internal Medicine|April 15, 1990
Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcomeF R Appelbaum, J Barrall, R Storb, et al.
Blood|September 15, 1995
Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-/efflux+ and MDR1+/efflux- casesC P Leith, I M Chen, K J Kopecky, et al.
Blood|July 15, 1992
Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemiaR Storb, M Pepe, H J Deeg, et al.
Pageof 49

Showing results (261-270 of 490) with videos related to

Sort By:
Pageof 49
Leukemia Research|March 30, 2000
A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemiaP J Rosen, C Rankin, D R Head, et al.
Genes, Chromosomes & Cancer|June 22, 2000
Twenty-four-color spectral karyotyping reveals chromosome aberrations in cytogenetically normal acute myeloid leukemiaF F Zhang, J L Murata-Collins, P Gaytan, et al.
Bone Marrow Transplantation|April 1, 1996
Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levelsT Demirer, C D Buckner, F R Appelbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1987
Marrow transplantation for acute nonlymphocytic leukemia following therapy for Hodgkin's diseaseM Sargur, C D Buckner, F R Appelbaum, et al.
Blood|August 15, 1991
Graft-versus-host disease prophylaxis with methotrexate/cyclosporine in children with severe aplastic anemia treated with cyclophosphamide and HLA-identical marrow graftsR Storb, J E Sanders, M Pepe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapyJ Mortimer, M A Blinder, S Schulman, et al.
Transplantation|November 1, 1992
Succinyl acetone plus methotrexate as graft-versus-host disease prophylaxis in DLA-haploidentical canine littermate marrow graftsR F Raff, R Storb, T Graham, et al.
Annals of Internal Medicine|April 15, 1990
Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcomeF R Appelbaum, J Barrall, R Storb, et al.
Blood|September 15, 1995
Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-/efflux+ and MDR1+/efflux- casesC P Leith, I M Chen, K J Kopecky, et al.
Blood|July 15, 1992
Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemiaR Storb, M Pepe, H J Deeg, et al.
Pageof 49